|This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.|
This educational activity will address the issue of adherence in the oncology patient. Adherence is one of the most important factors to address to increase the likelihood of treatment success. More oral chemotherapy agents are becoming available for oncology treatments, increasing the importance of adherence. Topics to be addressed include the incidence of non-adherence, reasons for non-adherence, and consequences of non-adherence. Strategies to remove barriers to non-adherence and improve the adherence rate will be discussed.
The target audience for this activity includes pharmacists. Upon completion of this activity, participants will be able to:
- Discuss the shift from intravenous to oral chemotherapy over the past few decades
- Assess the various dimensions of adherence
- Discuss how to manage patients who are non-adherent to oral chemotherapy
- Explain how to advocate for legislation that can improve access to oral chemotherapy
Benyam Muluneh, PharmD, BCOP, CPP
Clinical Pharmacist Practitioner
Adjunct Assistant Professor
Malignant Hematology Clinic
Chapel Hill, NC
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Benyam Muluneh does not have any relevant commercial and/or financial relationships to disclose.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 02-27-2020
Expiration Date: 02-27-2023
Pharmacists and Pharmacy Technicians
This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-089-H01-P/T has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers, and is provided at no cost to participants. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.
No external support has been received for this activity.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.